Myocardial cytoprotection and ischemic myocardial dysfunction correction in stable angina patients after transluminal balloon angioplasty or coronary artery stenting
The results of myocardial cytoprotection with mildronate and trimethazidine (Preductal MB) in stable angina patients with left ventricular (LV) myocardial dysfunction, including hibernation, are presented. All participants underwent transluminal balloon angioplasty. Mildronate and trimethazidine the...
Main Authors: | I. G. Gordeev, V. A. Lusov, E. A. Bekchiu, N. A. Volov, E. E. Ilina, A. Yu. Lebedeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2006-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1698 |
Similar Items
-
Myocardial cytoprotectors and lipid peroxidation in stable angina patients before and after myocardial revascularization
by: I. G. Gordeev, et al.
Published: (2005-06-01) -
METABOLIC MYOCARDIAL CYTOPROTECTORS IN THERAPY OF STABLE ISCHEMIC HEART DISEASE: EVIDENCE OF EFFECTIVENESS AND USE RECOMMENDATIONS
by: N. B. Perepech
Published: (2017-11-01) -
Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment
by: G. G. Semenkova, et al.
Published: (2007-04-01) -
Оценка жизнеспособности миокарда после реваскуляризации у больных с ишемичекой болезнью сердца
by: Игорь Владимирович Кузнецов
Published: (2015-02-01) -
Non-invasive imaging in detecting myocardial viability: Myocardial function versus perfusion
by: Iqbal A. Elfigih, et al.
Published: (2014-12-01)